Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis-Reference-Cited by-同舟云学术

Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis

Published:2022-12-22 Issue:4 Volume:53 Page:301-311
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Tahata Yuki¹,Sakamori Ryotaro¹^ORCID,Maesaka Kazuki¹,Doi Akira¹,Yamada Ryoko¹,Kodama Takahiro¹^ORCID,Hikita Hayato¹^ORCID,Miyazaki Masanori²,Nozaki Yasutoshi³,Kaneko Akira⁴,Oshita Masahide⁵,Tanaka Satoshi⁶,Imanaka Kazuho⁷,Hiramatsu Naoki⁸,Morishita Naoki⁹,Ohkawa Kazuyoshi¹⁰^ORCID,Yakushijin Takayuki¹¹,Sakakibara Mitsuru¹²,Iio Sadaharu¹³,Doi Yoshinori¹⁴,Tatsumi Tomohide¹,Takehara Tetsuo¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita, Osaka Japan

2. Osaka Police Hospital Osaka Japan

3. Kansai Rosai Hospital Amagasaki, Hyogo Japan

4. Japan Community Healthcare Organization Osaka Hospital Osaka Japan

5. Ikeda Municipal Hospital Ikeda, Osaka Japan

6. National Hospital Organization Osaka National Hospital Osaka Japan

7. Itami City Hospital Itami, Hyogo Japan

8. Osaka Rosai Hospital Sakai, Osaka Japan

9. Minoh City Hospital Minoh, Osaka Japan

10. Osaka International Cancer Institute Osaka Japan

11. Osaka General Medical Center Osaka Japan